logo
Select company
Select metric
95.83%Cash to Assets Ratio
VS
Market
99
Sector
98
Industry
96
History
61
$ 1.41Close
$ 0.55 - $ 2.35 52-Week Range
Ticker Information

Ticker

CNTX

Company Name

CONTEXT THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CONTEXT THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CNTX - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 87.15M$ 83.52M95.83%
3/31/2025$ 92.97M$ 89.35M96.11%
12/31/2024$ 98.13M$ 94.43M96.23%
9/30/2024$ 86.33M$ 84.8M98.23%
6/30/2024$ 102.71M$ 101.54M98.86%
3/31/2024$ 11.05M$ 10.09M91.29%
12/31/2023$ 16.06M$ 14.45M89.96%
9/30/2023$ 22.99M$ 21.68M94.29%
6/30/2023$ 27.76M$ 25.14M90.55%
3/31/2023$ 31.97M$ 29.77M93.13%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CONTEXT THERAPEUTICS INC is calculated as follows: CashnEq [ $ 341.04K ] / Assets [ $ 467.34K ]
(=) Cash to Assets [ 72.97% ]

CNTX - Cash to Assets Ratio, Last 5 years

18.55%

Minimum

Sep 30, 2021

98.86%

Maximum

Jun 30, 2024

86.01%

Average

93.69%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.77% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.93K
min0%
max40.71%
average9.77%
median6.41%
std9.51%